# Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)

Study · id `cardio:ct-nct06698159` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06698159](<https://clinicaltrials.gov/study/NCT06698159>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06698159

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 440 participants.

## Technical summary

Registry record NCT06698159. Randomized; double masking; primary purpose treatment. Start 2024-11-01 (actual); primary completion 2026-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 440 participants (planned count; ClinicalTrials.gov record NCT06698159, source copy `cardio:ctgov-nct06698159-2024-11-20`, retrieved 2026-10-26)
- Started: 2024-11-01 (actual) (ClinicalTrials.gov record NCT06698159, source copy `cardio:ctgov-nct06698159-2024-11-20`, retrieved 2026-10-26)
- Primary completion: 2026-05-01 (anticipated) (ClinicalTrials.gov record NCT06698159, source copy `cardio:ctgov-nct06698159-2024-11-20`, retrieved 2026-10-26)
- Completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT06698159, source copy `cardio:ctgov-nct06698159-2024-11-20`, retrieved 2026-10-26)
- Countries: Italy; Spain (ClinicalTrials.gov record NCT06698159, source copy `cardio:ctgov-nct06698159-2024-11-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06698159-2024-11-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)
- Acronym: WIDER-PVI
- Condition: Atrial Fibrillation
- Condition: Atrial Fibrillation (Paroxysmal)
- Intervention (Device): Cryoablation with cryoballoon 28 mm
- Intervention (Device): Cryoablation with cryoballoon 31 mm
- Lead sponsor: Hospital Universitario 12 de Octubre
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Hospital Universitario 12 de Octubre (`cardio:org-hospital-universitario-12-de-octubre`)

## Provenance

Content hash: 69d81f51871fbfee7b1577d4802972f7dc8ec0bb0d07d437177ec11331584da8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
